CA
NZ
UK
AU
IND
US
Retension Pharmaceuticals Inc. (NASDAQ:RTSN) was a prominent gainer in the US market on Friday, October 16, 2026, closing at $14.07 after advancing 15.23% on the day.
● It was at least the stock's sixth consecutive daily gain, helped by a healthcare rotation.
Actuate Therapeutics, Inc. (NASDAQ:ACTU) climbed on Friday, October 16, 2026, closing at $0.605, a gain of 21.02% for the session. The advance came against a broadly weaker market, with the Nasdaq Composite down 2.14% and the S&P 500 off 1.09% as an extended selloff …
● Truist's reasoning was not detailed, and no closing move for Alkermes was reported.
ALX Oncology Holdings, Inc. (NASDAQ:ALXO) advanced on Friday, October 16, 2026, closing at $1.06 for a gain of 6.00%. The rise is notable mainly because it ran counter to the broader tone of the session. US stocks fell in a risk-off day led by …
Armata Pharmaceuticals Inc. (NYSE American:ARMP) advanced on Friday, October 16, 2026, closing at $3.37, a gain of 9.06% for the session. The move placed the micro-cap biotech among the day’s stronger performers, which is notable given that the broader market was moving in the …
● The clearance for blarcamesine in Fragile X syndrome sets up a Phase 2a trial.
● Myriad Genetics, Moderna, Repligen and PacBio also fell sharply, with PacBio plunging.
Cryo-Cell International, Inc. (NYSE American:CCEL) rose sharply on Friday, October 16, 2026, closing at $4.420, a gain of 21.10% for the session. The move stood out against a weaker broad market, where the Nasdaq Composite fell 2.14% and the S&P 500 slipped 1.09% amid …
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a micro-cap biotechnology company, finished among the day’s gainers in a session that was otherwise defined by broad market weakness, closing at $4.52, up 4.39% on Friday, October 16, 2026.
Please wait processing your request...